Perrigo Company PLC

81 FDA enforcement actions

81 Total Recalls

0 Class I

81 Class II

0 Class III

Firm Details

Product Types: drug
States: MI

All Recalls

Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 10/26/2021 drug

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Class II: Risk 07/27/2021 drug

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.